[시장보고서]분자 파밍 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 작물원별, 기술별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

분자 파밍 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 작물원별, 기술별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

Molecular Pharming Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Crop Source, By Technology, By Application, By End User, By Region and Competition, 2020-2030F

상품코드 : 1878823

리서치사 : TechSci Research

발행일 : 2025년 11월

페이지 정보 : 영문 180 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,681,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500

￦ 8,165,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000

￦ 11,877,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 분자 파밍 시장은 2024년에 25억 6,000만 달러로 평가되었으며, 2030년까지 CAGR 8.00%로 성장하여 40억 6,000만 달러에 달할 것으로 예측됩니다.

분자 파밍은 식물, 동물 또는 미생물을 유전자 조작하여 의약품용 단백질, 백신, 기타 귀중한 치료용 화합물을 생산하는 바이오리액터로 기능하도록 하는 기술입니다. 시장 성장은 주로 비용 효율적인 바이오의약품에 대한 수요 증가와 생산 효율과 수율을 향상시키는 유전공학 기술의 지속적인 발전에 의해 주도되고 있습니다. 분자농업 플랫폼이 본래 가지고 있는 확장성과 적응력도 그 확장에 크게 기여하고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	25억 6,000만 달러
시장 규모 : 2030년	40억 6,000만 달러
CAGR : 2025-2030년	8%
가장 빠르게 성장하는 부문	바이오테크놀러지·제약 기업
최대 시장	북미

주요 시장 촉진요인

주요 시장 과제

주요 시장 동향

시장 규모 및 예측
- 금액별
시장 점유율과 예측
- 작물원별(옥수수, 보리, 담배, 홍화, 쌀, 알팔파)
- 기술별(유전자 건, 아그로인필트레이션, 일렉트로포레이션, 아그로박테리움 매개 유전자 도입, 기타)
- 용도별(재조합 항체, 호르몬, 백신, 산업용 효소, 단백질 및 단백질 기반 재료, 기술 시약, 영양 작물 원료, 기타)
- 최종사용자별(바이오테크놀러지·제약 기업, 위탁생산, 기타)
- 지역별
- 기업별(2024)
시장 맵

제6장 북미의 분자 파밍 시장 전망

시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
- 미국
- 캐나다
- 멕시코

제7장 유럽의 분자 파밍 시장 전망

시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인

제8장 아시아태평양의 분자 파밍 시장 전망

시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
- 중국
- 인도
- 일본
- 한국
- 호주

제9장 중동 및 아프리카의 분자 파밍 시장 전망

시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
- 사우디아라비아
- 아랍에미리트
- 남아프리카공화국

제10장 남미의 분자 파밍 시장 전망

시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
- 브라질
- 콜롬비아
- 아르헨티나

제11장 시장 역학

성장 촉진요인
과제

제12장 시장 동향과 발전

인수합병
제품 출시
최근 동향

제13장 세계의 분자 파밍 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협

제15장 경쟁 구도

Agrenvec S.L
Diamante SRL
Leaf Systems International Limited
Medicago Inc
Meristem Therapeutics S.A.
Moolec Science SA
ORF Genetics
Pfizer, Inc.
ProdiGene Inc
Protalix Biotherapeutics, Inc.

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

KSM

영문 목차

영문목차

The Global Molecular Pharming Market, valued at USD 2.56 Billion in 2024, is projected to experience a CAGR of 8.00% to reach USD 4.06 Billion by 2030. Molecular pharming involves the genetic engineering of plants, animals, or microorganisms to serve as bioreactors for producing pharmaceutical proteins, vaccines, and other valuable therapeutic compounds. The market's growth is primarily driven by the increasing demand for cost-effective biopharmaceuticals, coupled with continuous advancements in genetic engineering techniques that enhance production efficiency and yield. The inherent scalability and adaptability of molecular pharming platforms also contribute significantly to its expansion.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 2.56 Billion
Market Size 2030	USD 4.06 Billion
CAGR 2025-2030	8%
Fastest Growing Segment	Biotechnology & Pharmaceutical Companies
Largest Market	North America

Key Market Drivers

The Global Molecular Pharming Market is significantly propelled by continuous advancements in genetic engineering technologies. These innovations enable increasingly precise and efficient modification of organisms for pharmaceutical protein production, fostering the development of novel therapeutic compounds and enhancing production yields. For instance, according to Labiotech. eu, September 30, 2025, "CRISPR technology's next wave: Ten companies to watch in 2025", Chroma, a company building an epigenetic editing platform, secured $135 million in Series B funding in 2023, highlighting substantial investment directed towards refining gene-editing capabilities that underpin molecular pharming applications. Such technological progress, including advanced gene-editing tools and synthetic biology techniques, is crucial for overcoming previous limitations in expression levels and product quality, thereby expanding the feasibility and commercial viability of molecular pharming systems across various platforms like plants and microbial hosts.

Key Market Challenges

A significant challenge impeding the growth of the Global Molecular Pharming Market is the complex regulatory landscape and the stringent approval processes governing genetically modified organisms and their derived products, along with concerns regarding potential environmental contamination risks. This intricate web of regulations directly impacts market expansion by extending the time required to bring novel biopharmaceuticals to market and increasing associated development costs.

The extensive testing, data collection, and sequential regulatory hurdles for genetically modified products, including those produced through molecular pharming, contribute to a prolonged and costly approval pathway. According to EFPIA's 2024 Key Data, an average of 12-13 years elapses from the first synthesis of a new active substance until it reaches the market. This extended timeline delays the commercialization of products and the generation of revenue, thereby diminishing the attractiveness of investing in molecular pharming initiatives. The uncertainty and high capital expenditure linked to navigating these demanding regulatory environments make it more difficult for companies to secure funding and allocate resources to the development of pharming-derived therapeutics, consequently hampering overall market growth.

Key Market Trends

The Global Molecular Pharming Market is experiencing a notable shift due to the diversification of its applications into nutraceutical production. This trend highlights the expansion of molecular pharming beyond traditional pharmaceutical proteins into generating high-value compounds for the functional food and dietary supplement industries. The inherent scalability and cost-effectiveness of molecular pharming platforms, particularly plant-based systems, are well-suited for producing vitamins, antioxidants, and other health-promoting substances, addressing a rising consumer demand for natural and bio-enhanced products. According to the Council for Responsible Nutrition, in 2024, 75% of Americans continued to use dietary supplements, demonstrating sustained consumer interest. This consistent demand propels molecular pharming companies to explore new revenue streams.

Key Market Players

Agrenvec S.L
Diamante SRL
Leaf Systems International Limited
Medicago Inc
Meristem Therapeutics S.A.
Moolec Science SA
ORF Genetics
Pfizer, Inc.
ProdiGene Inc
Protalix Biotherapeutics, Inc.

Report Scope:

In this report, the Global Molecular Pharming Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Molecular Pharming Market, By Crop Source:

Maize
Barley
Tobacco
Safflower
Rice
Alfalfa

Molecular Pharming Market, By Technology:

Gene Gun
Agroinfiltration
Electroporation
Agrobacterium-Mediated Gene Transfer
Others

Molecular Pharming Market, By Application:

Recombinant Antibodies
Hormones
Vaccines
Industrial Enzymes
Proteins & Protein-Based Materials
Technical Reagents
Nutritional Crop Sources
Others

Molecular Pharming Market, By End User:

Biotechnology & Pharmaceutical Companies
Contract Manufacturing Organizations
Others

Molecular Pharming Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Molecular Pharming Market.

Available Customizations:

Global Molecular Pharming Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Molecular Pharming Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Crop Source (Maize, Barley, Tobacco, Safflower, Rice, Alfalfa)
- 5.2.2. By Technology (Gene Gun, Agroinfiltration, Electroporation, Agrobacterium-Mediated Gene Transfer, Others)
- 5.2.3. By Application (Recombinant Antibodies, Hormones, Vaccines, Industrial Enzymes, Proteins & Protein-Based Materials, Technical Reagents, Nutritional Crop Sources, Others)
- 5.2.4. By End User (Biotechnology & Pharmaceutical Companies, Contract Manufacturing Organizations, Others)
- 5.2.5. By Region
- 5.2.6. By Company (2024)
5.3. Market Map

6. North America Molecular Pharming Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Crop Source
- 6.2.2. By Technology
- 6.2.3. By Application
- 6.2.4. By End User
- 6.2.5. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Molecular Pharming Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Crop Source
    - 6.3.1.2.2. By Technology
    - 6.3.1.2.3. By Application
    - 6.3.1.2.4. By End User
- 6.3.2. Canada Molecular Pharming Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Crop Source
    - 6.3.2.2.2. By Technology
    - 6.3.2.2.3. By Application
    - 6.3.2.2.4. By End User
- 6.3.3. Mexico Molecular Pharming Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Crop Source
    - 6.3.3.2.2. By Technology
    - 6.3.3.2.3. By Application
    - 6.3.3.2.4. By End User

7. Europe Molecular Pharming Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Crop Source
- 7.2.2. By Technology
- 7.2.3. By Application
- 7.2.4. By End User
- 7.2.5. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Molecular Pharming Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Crop Source
    - 7.3.1.2.2. By Technology
    - 7.3.1.2.3. By Application
    - 7.3.1.2.4. By End User
- 7.3.2. France Molecular Pharming Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Crop Source
    - 7.3.2.2.2. By Technology
    - 7.3.2.2.3. By Application
    - 7.3.2.2.4. By End User
- 7.3.3. United Kingdom Molecular Pharming Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Crop Source
    - 7.3.3.2.2. By Technology
    - 7.3.3.2.3. By Application
    - 7.3.3.2.4. By End User
- 7.3.4. Italy Molecular Pharming Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Crop Source
    - 7.3.4.2.2. By Technology
    - 7.3.4.2.3. By Application
    - 7.3.4.2.4. By End User
- 7.3.5. Spain Molecular Pharming Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Crop Source
    - 7.3.5.2.2. By Technology
    - 7.3.5.2.3. By Application
    - 7.3.5.2.4. By End User

8. Asia Pacific Molecular Pharming Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Crop Source
- 8.2.2. By Technology
- 8.2.3. By Application
- 8.2.4. By End User
- 8.2.5. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Molecular Pharming Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Crop Source
    - 8.3.1.2.2. By Technology
    - 8.3.1.2.3. By Application
    - 8.3.1.2.4. By End User
- 8.3.2. India Molecular Pharming Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Crop Source
    - 8.3.2.2.2. By Technology
    - 8.3.2.2.3. By Application
    - 8.3.2.2.4. By End User
- 8.3.3. Japan Molecular Pharming Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Crop Source
    - 8.3.3.2.2. By Technology
    - 8.3.3.2.3. By Application
    - 8.3.3.2.4. By End User
- 8.3.4. South Korea Molecular Pharming Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Crop Source
    - 8.3.4.2.2. By Technology
    - 8.3.4.2.3. By Application
    - 8.3.4.2.4. By End User
- 8.3.5. Australia Molecular Pharming Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Crop Source
    - 8.3.5.2.2. By Technology
    - 8.3.5.2.3. By Application
    - 8.3.5.2.4. By End User

9. Middle East & Africa Molecular Pharming Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Crop Source
- 9.2.2. By Technology
- 9.2.3. By Application
- 9.2.4. By End User
- 9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Molecular Pharming Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Crop Source
    - 9.3.1.2.2. By Technology
    - 9.3.1.2.3. By Application
    - 9.3.1.2.4. By End User
- 9.3.2. UAE Molecular Pharming Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Crop Source
    - 9.3.2.2.2. By Technology
    - 9.3.2.2.3. By Application
    - 9.3.2.2.4. By End User
- 9.3.3. South Africa Molecular Pharming Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Crop Source
    - 9.3.3.2.2. By Technology
    - 9.3.3.2.3. By Application
    - 9.3.3.2.4. By End User

10. South America Molecular Pharming Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Crop Source
- 10.2.2. By Technology
- 10.2.3. By Application
- 10.2.4. By End User
- 10.2.5. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Molecular Pharming Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Crop Source
    - 10.3.1.2.2. By Technology
    - 10.3.1.2.3. By Application
    - 10.3.1.2.4. By End User
- 10.3.2. Colombia Molecular Pharming Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Crop Source
    - 10.3.2.2.2. By Technology
    - 10.3.2.2.3. By Application
    - 10.3.2.2.4. By End User
- 10.3.3. Argentina Molecular Pharming Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Crop Source
    - 10.3.3.2.2. By Technology
    - 10.3.3.2.3. By Application
    - 10.3.3.2.4. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Molecular Pharming Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Agrenvec S.L
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Diamante SRL
15.3. Leaf Systems International Limited
15.4. Medicago Inc
15.5. Meristem Therapeutics S.A.
15.6. Moolec Science SA
15.7. ORF Genetics
15.8. Pfizer, Inc.
15.9. ProdiGene Inc
15.10. Protalix Biotherapeutics, Inc.